))
The Role CDMOs Play in the Future of Medicine — A Conversation with JR Humbert of INCOG BioPharma Services
Manage episode 424223814 series 3580470
内容由Executive Platforms提供。所有播客内容（包括剧集、图形和播客描述）均由 Executive Platforms 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
At the 2024 edition of the Pharma Manufacturing World Summit held earlier this month in Boston, we spoke with JR Humbert, INCOG BioPharma Services’ VP Quality, about the crucial contributions CDMOs are making towards the future of medicine, both for large manufacturers and also for a whole range of new, small companies moving their Advanced Therapy Medicinal Products towards commercialization. What are the important issues pharmaceutical manufacturers need to be asking about and learning about as they choose how to partner with a third party to build up their capacity and capabilities? What does the working relationship need to look like from a quality perspective, from a compliance perspective, and from a day-to-day performance perspective? Where are Contract Development and Manufacturing Organizations going as a growing facet of this industry, and how are the best of them trying to become customer-centric to help best serve patients? For all this and more, give this episode a listen!
--
JR Humbert is currently the VP, Quality at INCOG BioPharma Services, and created and implemented the quality system at INCOG, which in three years went from company creation through successful FDA inspection in 3 years.
JR has over 20 years of pharmaceutical and biotechnology industry experience in validation, quality, technology transfer, process engineering, and program management. Some of JR’s previous companies include Piramal Pharma Solutions, Roche/Genentech, Hospira, and Cook Pharmica.
JR has participated in multiple global health authority inspections and developed inspection responses. JR has an MBA from Indiana University, and a BA in Chemistry and Biochemistry from the University of Colorado-Boulder.
--
INCOG BioPharma Services Inc. has been designed and built from decades of experience with a clear purpose: to deliver better CDMO services in the injectable drug product space.
With our dedicated team, best-in-class processes, and state-of-the-art equipment, we deliver meaningful results and stand-out customer experiences. We are here to strive for the best—for our team and for our customers. We are in it with you from the moment we start work on your project. We go above and beyond to understand your requirements, meet your needs, and foster a truly collaborative partnership.
Founded in June 2020, INCOG BioPharma Services offers development and manufacturing services to both early phase and late phase biopharmaceutical companies. We are located on the northeast corner of Indianapolis in Fishers, IN.
231集单集
分享
